ARK Genomic Revolution ETF Rating $51.64 +0.05 (+0.10%) Closing price 09/18/2026 04:10 PM EasternExtended Trading$52.06 +0.42 (+0.81%) As of 09/18/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsNews and TrendsOwnershipRatingsShort Interest ARK Genomic Revolution ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.57Holdings in ARKG have an aggregate rating of Moderate Buy based on 352 analyst ratings issued in the past year covering 25 companies (94.1% of the portfolio).ARKG Aggregate Price Target$51.64High Prediction$51.64Average Prediction$51.64Low Prediction$51.64Holdings in ARKG have an aggregate price target of $51.64 and a range of $51.64 to $51.64 covering 25 companies (94.1% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 ARKG Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.13%TXG10x Genomics$76.60-0.5%1.5276 of 5 stars2.24$44.00 -42.6%178.57%TWSTTwist Bioscience$166.99+7.3%1.8504 of 5 stars2.50$103.00 -38.3%12Analyst Forecast7.88%TEMTempus AI$77.84-3.1%1.8612 of 5 stars2.43$69.33 -10.9%21Trending NewsInsider TradeOptions Volume6.14%CRSPCRISPR Therapeutics$56.56-1.3%2.4144 of 5 stars2.59$67.94 20.1%17Gap DownHigh Trading Volume5.93%PSNLPersonalis$16.40+1.0%2.1469 of 5 stars2.30$14.54 -11.4%104.82%ABSIAbsci$9.65+4.1%2.7582 of 5 stars2.80$13.71 42.1%10Gap DownHigh Trading Volume4.44%GHGuardant Health$179.38-2.0%2.061 of 5 stars2.96$188.13 4.9%26Trending NewsAnalyst ForecastInsider Trade4.08%NTRANatera$369.39+0.8%1.9564 of 5 stars2.83$330.83 -10.4%23High Trading Volume3.95%ILMNIllumina$239.62-2.3%2.1915 of 5 stars2.44$199.13 -16.9%18High Trading Volume3.90%LLYEli Lilly and Company$1,152.62+0.0%4.8179 of 5 stars2.87$1,305.25 13.2%30Trending NewsAnalyst UpgradeAnalyst RevisionHigh Trading Volume3.80%CDNACareDx$53.83-0.8%2.5951 of 5 stars2.63$51.20 -4.9%83.54%BEAMBeam Therapeutics$24.95+1.1%2.2194 of 5 stars2.69$49.00 96.4%133.13%CMPSCompass Pathways$15.19+1.3%2.4361 of 5 stars2.88$23.36 53.8%172.41%RXRXRecursion Pharmaceuticals$3.83+8.2%1.7552 of 5 stars2.20$8.06 110.4%5News CoverageOptions VolumeHigh Trading Volume2.41%SDGRSchrodinger$29.02-4.0%1.0723 of 5 stars2.29$20.50 -29.4%7News CoverageOptions VolumeGap DownHigh Trading Volume2.36%ARCTArcturus Therapeutics$16.03-5.3%2.9668 of 5 stars2.60$23.00 43.5%10News Coverage2.32%NRIXNurix Therapeutics$25.44-0.2%2.1154 of 5 stars2.80$34.21 34.5%15High Trading Volume2.29%ADPTAdaptive Biotechnologies$28.61+0.2%1.8728 of 5 stars2.57$24.42 -14.7%7News CoverageInsider Trade2.25%WGSGeneDx$101.10-3.7%1.5935 of 5 stars2.89$89.57 -11.4%9News CoverageInsider Trade2.12%VCYTVeracyte$39.79-1.9%4.3103 of 5 stars2.82$55.78 40.2%11Analyst ForecastInsider TradeHigh Trading Volume2.07%BFLYButterfly Network$7.89-0.8%1.3448 of 5 stars2.40$6.56 -16.9%5Options Volume1.85%IONSIonis Pharmaceuticals$44.44-4.9%3.0593 of 5 stars2.73$90.80 104.3%22Analyst ForecastHigh Trading Volume1.76%NTLAIntellia Therapeutics$12.14-1.0%2.6814 of 5 stars2.35$20.98 72.8%23High Trading Volume1.49%ALMRAlamar Biosciences$34.85+8.9%1.5385 of 5 stars2.43$31.80 -8.8%7High Trading Volume1.42%PRMEPrime Medicine$3.12-0.6%2.5897 of 5 stars2.89$7.47 139.5%9News Coverage This page (BATS:ARKG) was last updated on 9/19/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
